NCT05688280
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05688280
Title Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (INJECTABL-1)
Acronym INJECTABL-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunophotonics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | DEU | CHE

Facility Status City State Zip Country Details
Miami Cardiac & Vascular Institute Coral Gables Florida 33146 United States Details
University of Louisville Physicians, PSC Louisville Kentucky 40202 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Institut Bergonie Bordeaux 33076 France Details
Hospitalier Pitie-Salpetriere Paris 75013 France Details
Hôpital Foch Suresnes 92150 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Johann Wolfgang Goethe-Univresitat Frankfurt/Main Frankfurt 60590 Germany Details
SLK-Kliniken Heilbronn GmbH Heilbronn 74078 Germany Details
Munchen Klinik Bogenhausen Munich 81925 Germany Details
IOSI Ospedale San Giovanni Bellinzona Bellinzona 6500 Switzerland Details
Inselspital Universitatsspital, Bern Bern CH-3010 Switzerland Details
Kantonsspital Graubunden Chur 7000 Switzerland Details
Kantonsspital St. Gallen Sankt Gallen CH-9007 Switzerland Details
University College London Hospitals London W1T 7HA United Kingdom Details
Churchill Hospital Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field